LymPro is ready to go for clinical trials now! But I wasn't able to discern from today's presentation exactly when we'd be able to start offering the 2 Georgetown tests. Gerald referred to "cornering the market" and offering this extensive "suite" to pharmas, which is what they've wanted, but is he talking about a year or two from now? My assumption has been that we offer Lympro in 2015 and that maybe sometime in 2016 the Georgetown tests will be added in. But Gerald didn't make that clear.

Regarding the MS drug, it sounded like we just have to do a 3 month validation test, that is no big deal, and then it will be ready to go. Maybe it will be producing revenue by May or June? Wow!! "I like it a lot!"